Dava J. Garcia
- Co-authors
- David S. AlbertsYei Mei PengG. Timothy BowdenRobin RobertsSydney E. SalmonPaul T. FantaKelli L. RunningAlton V. Hallum
- Topics
- Ovarian cancer diagnosis and treatment (7 papers)Chemotherapy-induced organ toxicity mitigation (3 papers)Endometrial and Cervical Cancer Treatments (2 papers)
- Partner nations
- United StatesFranceMexico
In The Last Decade
Dava J. Garcia
16 papers receiving 434 citations
Peers
Comparison fields: 5 of 85
- Oncology 144
- Molecular Biology 134
- Surgery 83
- Biomaterials 62
- Pulmonary and Respiratory Medicine 59
Countries citing papers authored by Dava J. Garcia
This map shows the geographic impact of Dava J. Garcia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dava J. Garcia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dava J. Garcia more than expected).
Fields of papers citing papers by Dava J. Garcia
This network shows the impact of papers produced by Dava J. Garcia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dava J. Garcia. The network helps show where Dava J. Garcia may publish in the future.
Co-authorship network of co-authors of Dava J. Garcia
This figure shows the co-authorship network connecting the top 25 collaborators of Dava J. Garcia. A scholar is included among the top collaborators of Dava J. Garcia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dava J. Garcia. Dava J. Garcia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 16 | |
| 5 | 6 | |
| 6 | 14 | |
| 7 | Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug. | 28 |
| 8 | 3 | |
| 9 | 139 | |
| 10 | 51 | |
| 11 | A Safety Review of Pegylated Liposomal Doxorubicin in the Treatment of Various Malignancies | 6 |
| 12 | 24 | |
| 13 | Salvage chemotherapy in recurrent or refractory squamous cell cancer of the uterine cervix. | 8 |
| 14 | Total platinum dose versus platinum dose intensification in ovarian cancer treatment. | 10 |
| 15 | Cisplatin in advanced cancer of the cervix: an update. | 71 |
| 16 | Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene. | 65 |
About Dava J. Garcia
Dava J. Garcia is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Dermatology, having authored 16 papers that have together received 448 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (7 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Obstetrics and Gynecology (52 citations), Reproductive Medicine (56 citations) and Oncology (144 citations). Dava J. Garcia has collaborated with scholars based in United States, France and Mexico. Frequent co-authors include David S. Alberts, David S. Alberts, Yei Mei Peng, G. Timothy Bowden, Robin Roberts, Sydney E. Salmon, Paul T. Fanta, Kelli L. Running, Alton V. Hallum and Kamal M. Abdo. Their work appears in journals such as Cancer, Drugs and Food and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.